NCT05837949

Brief Summary

The purpose of this study is to develop an application: MS Falls Insight Track (MS FIT) which allows patients to log their falls and near falls, view their MS relevant data and responses to the clinic intake survey as well as communicate with their care team about falls and receive educational material on falls prevention.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P75+ for not_applicable multiple-sclerosis

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 12, 2023

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

April 17, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 1, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

3.1 years

First QC Date

April 17, 2023

Last Update Submit

April 6, 2026

Conditions

Keywords

Multiple SclerosisMSFallsFallingClosed-loopDigital healthFalls trackingFalls preventionFitBitWearables

Outcome Measures

Primary Outcomes (5)

  • Percentage of patients initially use the tool (Adoption)

    This will be measured by calculating the percentage of patients who use the tool during the initial month of the study, and by the percentage of patient-clinical dyads who use the tool during the clinical visit

    6 months

  • Percentage of patient-clinician encounters initially use the tool (Adoption)

    This will be measured by calculating the percentage of patient-clinical dyads who use the tool during the clinical visit.

    6 months

  • Percentage of patients who continue to use the tool (Engagement)

    This will calculate the percentage of patients who continued to use the patient-facing tool at least quarterly

    12 months

  • Percentage of patient-clinician encounters use the tool during the 12-month visit (Engagement)

    This will be calculated by the percentage of the clinician-patient dyads in Arm 1 who use the in-visit dashboard at the 12-month clinical visit.

    12 months

  • Percentage of patients who respond to fall prompts (Adherence)

    Adherence will be measured by the percentage of falls reporting prompts adhered to per participant, as well as percentage of participants adhering to \>75% falls prompts

    12 months

Study Arms (1)

MS FIT: Falls Insight Track

EXPERIMENTAL

Participants in this arm will receive 12 months use of MS FIT mobile tool intervention

Behavioral: MS FIT: Falls Insight Track

Interventions

Participants will respond to a set of surveys every two weeks to increase communication on falls with their clinician.

MS FIT: Falls Insight Track

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of MS (relapsing or progressive) by 2017 McDonald Criteria18
  • Ages 18 and above
  • Any MS therapy, or no treatment
  • California resident to enable clinical telemedicine visits if warranted during the study visit
  • EDSS 2.0-8.0 (moderate to severe impairment, 7= wheelchair but independent transfers)
  • Fall risk, based on MSWS-12 score and previous report of a fall (Hopkins grade ≥1)
  • Technological criteria: availability of Wi-Fi in the home or workspace for connectivity.

You may not qualify if:

  • Cognitive dexterity or visual impairment that, in the opinion of the study neurologist (RB), would put the participant at risk or limit their ability to comply with the study protocol
  • Inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, San Francisco

San Francisco, California, 94158, United States

Location

Related Publications (1)

  • Block VJ, Koshal K, Wijangco J, Miller N, Sara N, Henderson K, Reihm J, Gopal A, Mohan SD, Gelfand JM, Guo CY, Oommen L, Nylander A, Rowson JA, Brown E, Sanders S, Rankin K, Lyles CR, Sim I, Bove R. A Closed-Loop Falls Monitoring and Prevention App for Multiple Sclerosis Clinical Practice: Human-Centered Design of the Multiple Sclerosis Falls InsightTrack. JMIR Hum Factors. 2024 Jan 11;11:e49331. doi: 10.2196/49331.

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Riley Bove, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: All participants will be given the MS FIT tool intervention
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2023

First Posted

May 1, 2023

Study Start

April 12, 2023

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

April 13, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

The deidentified dataset will be shared with qualified collaborators upon request, provision of CITI and other certifications, and data sharing agreement. We will share the results, once the data are complete and analyzed, with the scientific community and patient/clinician participants through abstracts, presentations and manuscripts.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
6 months post trial
Access Criteria
Qualified collaborators upon request, provision of CITI and other certifications, and data sharing agreement

Locations